fda bpc-157 warning 2025 not approved bpc 157 safety I'm sure your patients hit you up about BPC FDA panel is reviewing if – FDA considers widening access to

It's about restoring or amplifying what should already be happening which is why the side effect profiles of most therapeutic peptides are generally favorable, and why this category of treatment has attracted significant clinical research interest over the past decade

Endothelial protection : Guarding the delicate inner lining of blood vessels

Aggregates form when peptides clump together improperly

Injections are advised to circumvent potential absorption challenges in the gastrointestinal tract, particularly for those with known issues like Crohn's disease or irritable bowel syndrome, providing a more immediate replenishment compared to oral supplements, which may not be fully absorbed